Jim Simons Sangamo Therapeutics, Inc Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,168,107 shares of SGMO stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,168,107
Previous 3,084,877
2.7%
Holding current value
$1.49 Million
Previous $3.15 Million
33.57%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.41 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.23 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.07 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2MShares$939,0800.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $73.6M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...